Clinical Characteristics of Premenstrual Syndrome/Premenstrual Dysphoric Disorder Co-Morbid with Panic Disorder and the Effectiveness of Selective Serotonin Reuptake Inhibitors in Its Treatment
Premenstrual syndrome (PMS) is often co-morbid with panic disorder (PD). Selective serotonin reuptake inhibitors (SSRis) are the first-line treatment for both PMS and PD when they manifest separately, but their co-occurrence often complicates the treatment. Our objectives were to evaluate the clinic...
Saved in:
| Main Authors: | Rossitza Iakimova, Daniil Aptalidis, Milena Pandova, Maria Stoyanova, Maya Stoimenova-Popova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University - Pleven
2019-08-01
|
| Series: | Journal of Biomedical & Clinical Research |
| Subjects: | |
| Online Access: | https://jbcr.arphahub.com/article/34530/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the psychometric properties of the Premenstrual Symptoms Screening Tool (PSST) among Bangladeshi adolescent girls
by: Md. Saiful Islam, et al.
Published: (2025-07-01) -
Premenstrual syndrome as a risk factor for postpartum depression
by: A. Е. Sidorov, et al.
Published: (2024-11-01) -
The role of the neuroinflammation and stressors in premenstrual syndrome/premenstrual dysphoric disorder: a review
by: Ming Cheng, et al.
Published: (2025-03-01) -
Premenstrual dysphoric disorder: A controversial new diagnosis
by: Jeppe Bennekou Schroll, et al.
Published: (2022-05-01) -
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
by: Novick D, et al.
Published: (2016-02-01)